Holly Hill

8PUBLICATIONS
64CO-AUTHORS
Molecular targetsTumour immunologyPredictive and prognostic markersApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Immunogenetics (incl. genetic immunology)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Apr 08, 2026
Correction: Exploiting PRMT5 as a target for combination therapy in mantle cell lymphoma characterized by frequent ATM and TP53 mutations.

Yuxuan Che, Yang Liu, Yixin Yao

|Oct 07, 2024
Author Correction: Longitudinal single-cell profiling reveals molecular heterogeneity and tumor-immune evolution in refractory mantle cell lymphoma.

Shaojun Zhang, Vivian Changying Jiang, Guangchun Han

|Oct 02, 2024
Targeting the Epidermal Growth Factor Receptor Pathway in Chemotherapy-Resistant Triple-Negative Breast Cancer: A Phase II Study.

Clinton Yam, Miral Patel, Holly A Hill

|Aug 04, 2023
Integrative Prognostic Machine Learning Models in Mantle Cell Lymphoma.

Holly A Hill, Preetesh Jain, Chi Young Ok

|Feb 16, 2023
Exploiting PRMT5 as a target for combination therapy in mantle cell lymphoma characterized by frequent ATM and TP53 mutations.

Yuxuan Che, Yang Liu, Yixin Yao

|Nov 19, 2021
Ibrutinib With Rituximab in First-Line Treatment of Older Patients With Mantle Cell Lymphoma.

Preetesh Jain, Shuangtao Zhao, Hun Ju Lee

Pageof 2

Frequent Collaborators

7 joint publications

Michael Wang

5 joint publications

Chi Young Ok

5 joint publications

Preetesh Jain

3 joint publications

Shaojun Zhang